Pfizer Inc.
THERAPEUTIC ANTIBODIES AND THEIR USES
Last updated:
Abstract:
The present invention relates bispecific antibodies that specific binds to BCMA (B-Cell Maturation Antigen) and CD3 (Cluster of Differentiation 3). Method of making the bispecific antibodies and method of using the bispecific antibodies for the treatment of multiple myeloma are also provided.
Status:
Application
Type:
Utility
Filling date:
21 Dec 2020
Issue date:
24 Jun 2021